Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.43 |
| ▸ | KDM6B | O15054 | 1/20 | 0.43 |
| ▸ | KDM5C | P41229 | 1/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL2861696 | 0.96 | LMNA (0.41) | EGLN1KDM6BKDM5CPHF8KDM2A | |
| SCHEMBL4029579 | 0.94 | EGLN1 (0.39) | EGLN1KDM6BKDM5CPHF8KDM2A | |
| SCHEMBL645070 | 0.91 | CA12 (0.45) | CA12CA1CA2CA3CA4 | |
| SCHEMBL6178633 | 0.91 | CA12 (0.37) | EGLN1KDM6BKDM5CPHF8KDM2A | |
| SCHEMBL791222 | 0.88 | LMNA (0.50) | LMNAEPHX2MAPTTSHRAKR1B1 | |
| SCHEMBL793167 | 0.88 | TSHR (0.52) | LMNAEPHX2CYP1A2TSHRAKR1B1 | |
| SCHEMBL8087700 | 0.86 | LMNA (0.53) | LMNAEPHX2MAPTTSHRALDH1A1 | |
| SCHEMBL10414871 | 0.86 | LMNA (0.53) | LMNAEPHX2MAPTTSHRALDH1A1 | |
| SCHEMBL4896865 | 0.86 | LMNA (0.53) | LMNAEPHX2MAPTTSHRALDH1A1 | |
| SCHEMBL6737870 | 0.86 | LMNA (0.53) | LMNAEPHX2MAPTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-117447676-A | Degradable elastic material and preparation method thereof | 上海沐深新材料科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| WO-2024018436-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC (HU) | 2024-01-25 | — | — | WO | claimed |
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | BIOME BIOPLASTICS LIMITED (GB) | 2023-11-07 | — | — | US | claimed |
| WO-2022229129-A1 | RECYCLING OF POLYESTER FIBRES FROM TEXTILES | TEXTILE CHANGE APS (DK) | 2022-11-03 | — | — | WO | claimed |
| US-11471563-B2 | Preparing method of nerve conduits | WIREGENE CO., LTD. (KR) | 2022-10-18 | — | — | US | claimed |
| EP-3135699-B1 | CATALYST COMPONENT FOR PROPYLENE POLYMERIZATION, PREPARATION METHOD THEREFOR AND CATALYST HAVING SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2021-07-21 | — | — | EP | claimed |
| CN-108026350-B | Two-component composition | SIKA技术股份公司 | 2021-02-19 | — | — | CN | claimed |
| EP-3775249-A2 | PROCESS FOR OXIDISING A SUBSTRATE | Biome Bioplastics Limited (GB) | 2021-02-17 | — | — | EP | claimed |
| EP-1592406-A2 | LIPOPHILIC COMPOSITIONS | PHARES PHARMACEUTICAL RESEARCH N.V. (AN) | 2005-11-09 | — | — | EP | claimed |
| EP-1511811-A2 | OIL-SOLUBLE PIGMENT COMPOSITIONS | PHARES PHARMACEUTICAL RESEARCH N.V. (AN) | 2005-03-09 | — | — | EP | claimed |
| WO-2004071494-A2 | LIPOPHILIC COMPOSITIONS | PHARES PHARMACEUTICAL RESEARCH N.V. (AN) | 2004-08-26 | — | — | WO | claimed |
| US-20040115255-A1 | Method and composition for solubilising a biologically active compound with low water solubility | PHARES PHARMACEUTICAL RESEARCH N.V. | 2004-06-17 | — | — | US | claimed |
| WO-2003102116-A2 | OIL-SOLUBLE PIGMENT COMPOSITIONS | PHARES PHARMACEUTICAL RESEARCH N.V. (NL) | 2003-12-11 | — | — | WO | claimed |
| WO-2003023394-A2 | KIT FOR SCREENING COMPOUNDS WITH LOW WATER SOLUBILITY | PHARES PHARMACEUTICAL RESEARCH N.V. (AN) | 2003-03-20 | — | — | WO | claimed |
| US-4704164-A | VISUALIZATION OF COLOR BEFORE SINTERING DENTAL RESTORATIONS | FORSYTH DENTAL INFIRMARY FOR CHILDREN (US) | 1987-11-03 | — | — | US | claimed |
| EP-0234945-A2 | Dental colour shade kit and method of dental shade selection | FORSYTH DENTAL INFIRMARY FOR CHILDREN (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0201334-A2 | Preparations for making sintered procelain products and methods of making such products | FORSYTH DENTAL INFIRMARY FOR CHILDREN (US) | 1986-11-12 | — | — | EP | claimed |
| US-4209438-A | CROSSLINKED POLYESTER IN DIFUNCTIONAL CARBOXYLIC ESTER SOLVENT | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1980-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807886-B2 | Process for the preparation of copolymers derived from 2,4- or 2,5-pyridinedicarboxylic acid | HPD, PGD, PCCA | EGLN1 1462/4885KDM6B 647/4885KDM5C 261/4885 |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | EGLN1 2948/4885KDM6B 1396/4885KDM5C 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.